Market Overview:
The global plasmapheresis device market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising demand for plasma-derived products, and technological advancements in plasmapheresis devices. Based on type, the global plasmapheresis device market is segmented into source plasma collection and therapeutic plasmapheresis. The source plasma collection segment is further divided into automated blood collectors and manual blood collectors. The therapeutic plasmapheresis segment is further divided into immunoglobulin therapy, erythropoietin therapy, and others (including dialysis). Based on application, the global plasmapheresis device market is segmented into biopharmaceutical companies, hospitals & clinics, and others (including research institutes and diagnostic centers). Geographically, the global Plasmapherses Device Market has been segregated into North America,, Latin America,, Europe,, Asia Pacificand Middle East & Africa . Some of the major players operating in this market are Baxter International Inc., Becton Dickinson & Company., Cerus Corporation., Grifols SA.
Product Definition:
A plasmapheresis device is a medical device that is used to remove plasma from the blood. The importance of plasmapheresis devices is that they can be used to treat a variety of conditions, including autoimmune diseases, neurological disorders, and certain types of cancer.
Source Plasma Collection:
Plasmapheresis is a blood separation process that separates the blood into its components. The source plasma collection is used for this procedure and it's also known as apheresis or fractionation. Source Plasma Collection (SPC) devices are majorly used in the treatment of chronic diseases such as sickle cell disease, thalassemia, and leukemia.
Therapeutic Plasmapheresis:
Therapeutic Plasmapheresis is a process of separating the blood cells by their function or ability to produce antibodies. It's major use is in treating patients with chronic immune disorders such as lupus, rheumatoid arthritis, multiple sclerosis and other autoimmune diseases. Therapeutic plasmapheresis can also be used for treatment of cancer and certain metabolic disorders like Gaucher disease & Fabry disease among others.
Application Insights:
The biopharmaceutical companies application segment accounted for the largest revenue share in 2016. This is due to factors such as high usage of plasmapheresis devices for drug development and manufacturing of therapeutic proteins. For instance, ¢â‚¬Å“Plasma Protein Therapeutics¢â‚¬ (PPT) are being developed by Biogen, Inc., which are intended for use in the treatment of various life-threatening diseases including hemophilia and von Willebrand disease.
Furthermore, hospitals & clinics application segment is expected to witness lucrative growth over the forecast period owing to rising incidences of chronic diseases such as cancer and autoimmune disorders that require a constant flow of blood cells transfused into patients every 2 weeks or so.
Regional Analysis:
North America held the largest revenue share in 2017. The presence of key players, favorable reimbursement policies, and rising prevalence of blood disorders are some factors responsible for its dominance. For instance, under the Patient Protection and Affordable Care Act (PPACA), most healthcare providers are required to offer a co-pay free program that covers the cost of plasma collection kit for patients with chronic diseases such as cancer or diabetes. This encourages many people to donate plasma which is further expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing awareness about plasmapheresis treatment among patients & physicians and growing biopharmaceutical industry in this region.
Growth Factors:
- Increasing incidence of autoimmune diseases: The global Plasmapheresis Device market is expected to grow at a CAGR of 5.5% during the forecast period owing to the increasing incidence of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis (MS).
- Growing demand for plasma-derived therapies: The growth in the Plasmapheresis Device market is also attributed to the growing demand for plasma-derived therapies for various indications such as hemophilia, immunodeficiency disorders, and neurological disorders.
- Technological advancements in plasmapheresis devices: The technological advancements in plasmapheresis devices are propelling their adoption across hospitals and clinics worldwide. This is resulting in an increase in the number of patients being treated with plasmapheresis therapy.
- Rising geriatric population: The geriatric population is more susceptible to develop chronic diseases such as autoimmune diseases, which are characterized by inflammation that can be effectively managed with plasmapheresis therapy sessions.. This is expected to drive the growth of the global Plasmapheresis Device market during the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasmapheresis Device Market Research Report
By Type
Source Plasma Collection, Therapeutic Plasmapheresis
By Application
Biopharmaceutical Companies, Hospitals & Clinics, Others
By Companies
Fresenius Medical Care, Haemonetics Corporation, Fenwal, Terumo BCT, Asahi Kasei Medical, Nikkiso, Nigale Biomedical Inc, Kawasumi Laboratories, B. Braun Melsungen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Plasmapheresis Device Market Report Segments:
The global Plasmapheresis Device market is segmented on the basis of:
Types
Source Plasma Collection, Therapeutic Plasmapheresis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Hospitals & Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care
- Haemonetics Corporation
- Fenwal
- Terumo BCT
- Asahi Kasei Medical
- Nikkiso
- Nigale Biomedical Inc
- Kawasumi Laboratories
- B. Braun Melsungen
Highlights of The Plasmapheresis Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Source Plasma Collection
- Therapeutic Plasmapheresis
- By Application:
- Biopharmaceutical Companies
- Hospitals & Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasmapheresis Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A plasmapheresis device is a medical device that uses centrifugal force to remove plasma from the blood. Plasma is the liquid portion of blood and contains proteins, glucose, minerals, and other substances.
Some of the major players in the plasmapheresis device market are Fresenius Medical Care, Haemonetics Corporation, Fenwal, Terumo BCT, Asahi Kasei Medical, Nikkiso, Nigale Biomedical Inc, Kawasumi Laboratories, B. Braun Melsungen.
The plasmapheresis device market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasmapheresis Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasmapheresis Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasmapheresis Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasmapheresis Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasmapheresis Device Market Size & Forecast, 2018-2028
4.5.1 Plasmapheresis Device Market Size and Y-o-Y Growth
4.5.2 Plasmapheresis Device Market Absolute $ Opportunity
Chapter 5 Global Plasmapheresis Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Plasmapheresis Device Market Size Forecast by Type
5.2.1 Source Plasma Collection
5.2.2 Therapeutic Plasmapheresis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Plasmapheresis Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Plasmapheresis Device Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Hospitals & Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasmapheresis Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasmapheresis Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Plasmapheresis Device Analysis and Forecast
9.1 Introduction
9.2 North America Plasmapheresis Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Plasmapheresis Device Market Size Forecast by Type
9.6.1 Source Plasma Collection
9.6.2 Therapeutic Plasmapheresis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Plasmapheresis Device Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Hospitals & Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Plasmapheresis Device Analysis and Forecast
10.1 Introduction
10.2 Europe Plasmapheresis Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Plasmapheresis Device Market Size Forecast by Type
10.6.1 Source Plasma Collection
10.6.2 Therapeutic Plasmapheresis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Plasmapheresis Device Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Hospitals & Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Plasmapheresis Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Plasmapheresis Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Plasmapheresis Device Market Size Forecast by Type
11.6.1 Source Plasma Collection
11.6.2 Therapeutic Plasmapheresis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Plasmapheresis Device Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Hospitals & Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Plasmapheresis Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Plasmapheresis Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Plasmapheresis Device Market Size Forecast by Type
12.6.1 Source Plasma Collection
12.6.2 Therapeutic Plasmapheresis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Plasmapheresis Device Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Hospitals & Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Plasmapheresis Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Plasmapheresis Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Plasmapheresis Device Market Size Forecast by Type
13.6.1 Source Plasma Collection
13.6.2 Therapeutic Plasmapheresis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Plasmapheresis Device Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Hospitals & Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasmapheresis Device Market: Competitive Dashboard
14.2 Global Plasmapheresis Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Medical Care
14.3.2 Haemonetics Corporation
14.3.3 Fenwal
14.3.4 Terumo BCT
14.3.5 Asahi Kasei Medical
14.3.6 Nikkiso
14.3.7 Nigale Biomedical Inc
14.3.8 Kawasumi Laboratories
14.3.9 B. Braun Melsungen
